MinK-related protein (MiRP1, KCNE2) interacts with the hyperpolarization-activated, cyclic nucleotide gated (HCN) family of pacemaker channels to alter channel gating in heterologous expression systems. Given the high expression levels of MiRP1 and HCN subunits in the cardiac sinoatrial node and the contribution of pacemaker channel function to impulse initiation in that tissue, such an interaction could be of considerable physiological significance. However, the functional evidence for MiRP1/HCN interactions in heterologous expression studies has been accompanied by inconsistencies between studies in terms of the specific effects on channel function. To evaluate the effect of MiRP1 on HCN expression and function in a physiological context, we used an adenovirus approach to over-express an HA tagged MiRP1 (HA-MiRP1) and HCN2 in neonatal rat ventricular myocytes, a cell type that expresses both MiRP1 and HCN2 message at low levels. HA-MiRP1 co-expression with HCN2 resulted in a 4-fold increase in maximal conductance of pacemaker currents compared to HCN2 expression alone.
SUMMARY
MinK-related protein (MiRP1, KCNE2) interacts with the hyperpolarization-activated, cyclic nucleotide gated (HCN) family of pacemaker channels to alter channel gating in heterologous expression systems. Given the high expression levels of MiRP1 and HCN subunits in the cardiac sinoatrial node and the contribution of pacemaker channel function to impulse initiation in that tissue, such an interaction could be of considerable physiological significance. However, the functional evidence for MiRP1/HCN interactions in heterologous expression studies has been accompanied by inconsistencies between studies in terms of the specific effects on channel function. To evaluate the effect of MiRP1 on HCN expression and function in a physiological context, we used an adenovirus approach to over-express an HA tagged MiRP1 (HA-MiRP1) and HCN2 in neonatal rat ventricular myocytes, a cell type that expresses both MiRP1 and HCN2 message at low levels. HA-MiRP1 co-expression with HCN2 resulted in a 4-fold increase in maximal conductance of pacemaker currents compared to HCN2 expression alone.
HCN2 activation and deactivation kinetics also changed, being significantly more rapid for voltages between -60 and -95 mV when HA-MiRP1 was co-expressed with HCN2. However, the voltage dependence of activation was not affected. Co-immunoprecipitation experiments demonstrated that expressed HA-MiRP1 and HCN2, as well as endogenous MiRP1 and HCN2, co-assemble in ventricular myocytes. The results indicate that MiRP1 acts as a beta subunit for HCN2 pacemaker channel subunits and alters channel gating at physiologically relevant voltages in cardiac cells.
INTRODUCTION
MinK-related protein (MiRP1, KCNE2) is purported to be a beta subunit for several voltage gated potassium channels, including the rapid delayed rectifier (1), slow delayed rectifier (2) and transient outward current (3) . In addition, we have reported that it can act as a beta subunit for the hyperpolarization-activated, cyclic nucleotide gated (HCN) family of pacemaker channels (4) . We found that co-expression of MiRP1 with HCN1 or HCN2 in Xenopus oocytes resulted in larger and more rapidly activating currents than when either HCN isoform was expressed alone, but that MiRP1 did not shift the midpoint of activation of either isoform.
Further, co-immunoprecipitation experiments involving HA-tagged MiRP1 and HCN1 demonstrated that the two proteins interact when co-expressed in oocytes.
A more recent study demonstrated MiRP1 interaction with the HCN4 isoform. Here, coexpression with MiRP1, either in oocytes or CHO cells, also resulted in increased current amplitude, but this was associated with slowing of kinetics and a negative shift of the midpoint of activation (5) . However, another laboratory did not detect any effect of MiRP1 when coexpressed in HEK293 cells with either HCN4 or an HCN1-HCN4 tandem construct (6) . Finally, a study of MiRP1 and HCN2 co-expression in CHO cells reported a reduced time dependent current component and increased instantaneous component, compared to HCN2 expression alone (7).
Thus, depending on the HCN isoform and cell background, MiRP1 has been reported to speed, slow or not affect kinetics of activation; increase, decrease or not affect current amplitude; and shift or not shift voltage dependence of HCN channels. Since message for both HCN subunits and MiRP1 proteins are expressed at high abundance in the cardiac sinoatrial node (4) and conducting system (8) , interaction of these subunits and subsequent change of channel function within a myocardial cell could have a major impact on cardiac rhythm. To address this question, we have co-expressed MiRP1 and HCN2 in cultures of neonatal rat ventricular myocytes. These cultures normally exhibit spontaneous activity, primarily express message for the HCN2 isoform (9) , and possess a native pacemaker current that is small and therefore readily distinguished from the current resulting from over-expressed channels (10) .
EXPERIMENTAL PROCEDURES

Cell isolation and culture
Neonatal rats were sacrificed and the ventricles removed in accordance with Institutional Animal Care and Use Committee protocols of Columbia University. A standard trypsin dissociation method was employed to prepare newborn ventricle cell cultures (11) . The cells were preplated to reduce fibroblast proliferation, cultured initially in serum-containing medium and switched to serum free medium after 24 hours. For voltage clamp experiments, 6-day old monolayer cultures were resuspended by brief (2-3 min) exposure to 0.25 % trypsin, then the cells replated onto fibronectin-coated coverslips and studied within 2-8 hours. For coimmunoprecipitation studies, 6-day old cultures were harvested as described below.
Expression of HCN2, MiRP1 and MinK
For increased expression efficiency, we employed an adenoviral construct of mouse HCN2 (Accession# AJ225122) prepared as previously described (10) . In addition, the DNA fragment of rat MiRP1 (Accession# AF071003) with an HA tag at the C terminal was first cut out from its original vector pRc/CMV2 at EcoRI and SpeI and then subcloned into pDC516 at EcoRI and SmaI. The resulting pDC516-mHCN2 or pDC516-MiRP1-HA shuttle plasmid was co-transfected with a 35.5 kb E1-deleted Ad genomic plasmid pBHGfrt∆E1,3FLP (AdMax™) into E1-complementing HEK293 cells. The HA tag was added to MiRP1 to facilitate detection of MiRP1 protein, and was previously shown not to affect the ability of MiRP1 to increase HCN currents (4) . The adenoviral construct of HCN2 (AdHCN2) or MiRP1 with the HA tag (AdHAMiRP1) was subsequently harvested and CsCl purified. An adenoviral vector of GFP (AdGFP) was constructed the same way as AdHCN2 or AdHA-MiRP1 and used to maintain a constant total viral load under all experimental conditions. It has been demonstrated that GFP itself does not alter the characteristics of HCN2 channels in the myocytes (10) . Finally, for negative control experiments, human MinK (Accession# NM000219) in pBlueScript R vector (Open Biosystems) was subcloned into pDC516-IRES-GFP at EcoRI and SalI and used to prepare an adenovirus that co-expressed MinK and GFP (AdMinK-GFP). The functionality of AdMinK-GFP was confirmed in separate experiments measuring its effect on the slow delayed rectifier current (data not shown).
Infection of neonatal cells with the appropriate adenoviruses (e.g. 
Membrane extraction and immunochemistry
To prepare membranes from myocyte cultures, the culture medium was first aspirated from the 100-mm dishes and the infected myocytes rinsed with ice-cold Ca 2+ /Mg 2+ free saline, 8 mL/dish, which contained 33 mM NaCl, 4.7 mM KCl, 20 mM HEPES, and 16.5 mM dextrose.
Then 0.5 mL/dish of ice-cold homogenization buffer (HB) which contained 20 mM Tris-HCl (pH 7.5), 2 mM EDTA, 2 mM EGTA, 0.1 mM Sodium Orthovanadate, 0.042 % β-mercaptoethanol, 0.05 mg/mL Aprotinin, 0.05 mg/mL Benzamidin, 0.1 mM Leupeptin, 1 mM PMSF, and 0.005 mM Pepstatin A was added. The myocytes were scraped from each dish and transferred into 1.5 mL Eppendorf ultracentrifuge tubes and sonicated (20 pulses) at 4°C. The preparations were then spun at 185,000xg for 1 hour at 4°C and the myocyte membrane fraction was extracted and collected in the form of pellets for immunochemistry experiments.
The tissues for membrane preparations from rat neonatal ventricle or canine sinoatrial node (0.5 g) were homogenized in 10-fold volume (wt/vol) of ice-cold 10 mM NaHCO 3 , 10 mM histidine with protease inhibitor cocktail (Roche Diagnostics, Mannheim, Germany) with five 10-sec bursts at full speed on a Polytron homogenizer (Brinkmann, Westbury, NY). The homogenate was centrifuged for 10 min at 500xg, and the supernatant for 90 min at 100,000xg.
For both culture and tissue preparation, the membrane pellet was resuspended in 1 mL of 25 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 1 % Triton X-100, and 0.5 % NP-40. at the end of a 6-sec hyperpolarizing step ranging from -35 to -125 mV with decrements of 10 mV from a holding potential of -35 mV. The hyperpolarizing step was followed by an 8-sec step to -125 mV to record tail current, then a 0.5-sec pulse to +5 mV to ensure full deactivation.
Electrophysiological recording and data analysis
Tail currents were measured at -125 mV to avoid contamination by currents present at less negative voltages. The current-voltage (I-V) relation was constructed from the current measured at the end of the 6-sec hyperpolarizing steps. Then the I-V curve was fitted to the relation I = g max * y * (V -E rev ), in which y = 1 / (1 + exp ((V -V 1/2 ) / K)). The parameters g max and E rev are the maximum conductance and reversal potential of HCN2 channels, respectively, while V 1/2 and K represent the voltage where ½ the channels are activated and slope factor of the activation relation, respectively. E rev was determined by a protocol in which HCN2 currents were generated by a hyperpolarizing pre-pulse to -125 mV followed by deactivating steps ranging from -95 mV to 0 mV in increments of 5 mV. E rev is the voltage where the current reversed its direction. Tail currents, plotted against test voltages and fitted with the Boltzmann function (I tail = I tail,max / (1 + exp ((V -V 1/2 ) / K))) were used to determine V 1/2 and K.
Kinetics of activation were determined by a single exponential fit to the early time course of the current activated by hyperpolarization; the initial delay and any late slow activation were ignored. Kinetics of deactivation were determined by a single exponential fit of the time course of the current trace at each test voltage after activation by a pre-pulse to -125 mV. For both activation and deactivation, the duration of the trace being fit was ≥ 3x the measured time constant to ensure accuracy.
All data are presented as mean±S.E.M. Statistical significance was examined by t-test or ANOVA followed by pairwise multiple comparisons (Holm-Sidak method) as appropriate, and determined at p < 0.05.
RESULTS
Co-expression of HA-MiRP1 increases the magnitude of HCN2 current
HCN2 channels delivered via an adenoviral vector (AdHCN2) are well expressed in the ventricular myocytes of neonatal rats (10) . As illustrated in figure 1 , the magnitude of expressed HCN2 current was greater when co-infected with AdHA-MiRP1 (compared to control cultures co-infected with AdGFP), indicating that HA-MiRP1 co-expression upregulates HCN2 channel expression or otherwise increases current magnitude in the myocytes.
Since it has been reported that the instantaneous component of HCN2 current could be regulated in a heterologous system by co-expression of MiRP1 (7), we examined if this also is the case for the co-expression of HCN2 with MiRP1 in cardiac myocytes. We did not observe a 
Co-expression of HA-MiRP1 accelerates the gating kinetics of HCN2 channels
Although HA-MiRP1 does not alter the voltage dependence of expressed HCN2 channels in myocytes, it does alter the gating kinetics. Figure 4A shows representative HCN2 current traces in the presence and absence of HA-MiRP1. The holding potential was -35 mV, and the hyperpolarizing voltage was -85 mV. It is evident that HCN2 channels activate faster when co-expressed with HA-MiRP1. In addition, when membrane potential was depolarized after stepping to -125 mV to fully activate the HCN2 channels, faster deactivation kinetics of HCN2 channels also were observed with co-expression of HA-MiRP1. Figure 4B illustrates such accelerated deactivation kinetics of HCN2 channels at -70 mV in the presence of HAMiRP1. The complete relationship between gating kinetics (both activation and deactivation) and membrane potential is illustrated in figure 4C for cells expressing HCN2 with and without HAMiRP1 co-expression. The differences in the gating kinetics of HCN2 channels expressed with or without HA-MiRP1 are statistically significant and the kinetics differ significantly at physiologically relevant voltages, between -60 and -95 mV.
As an additional test of the specificity of the effect of MiRP1 on HCN2 currents, in a separate series of experiments we measured expressed HCN2 in the presence or absence of coexpressed MinK. There was no statistically significant difference in amplitude, midpoint, slope factor, kinetics or instantaneous component of the expressed pacemaker current (n=13).
HA-MiRP1 co-assembles with HCN2 as a protein complex
We first asked if native HCN2 and MiRP1 proteins could be detected in neonatal rat ventricle. We used tissue rather than cell cultures in this case, and compared neonatal rat ventricle to canine sinoatrial node, since message for both MiRP1 and HCN are high in this region of the heart. Both HCN2 and MiRP1 were detected in both tissues by immunoprecipitation with anti-HCN2 and anti-MiRP1, respectively (figure 5A and B, left 2 lanes).
We next asked if we could detect both native and expressed HCN2 in the neonatal ventricle cultures. HCN2 was detected in cultures infected only with AdGFP, however the quantity of native protein was more than an order of magnitude less than HCN2 in AdHCN2 infected cultures ( figure 5A, right 2 lanes) . In figure 5A , the two bands representing native 
DISCUSSION
The results in this study demonstrate that: 1) expressed HCN2 and HA-MiRP1 proteins co-assemble to form a functional complex in cardiac myocytes; 2) HA-MiRP1 when coexpressed in cardiac myocytes increases HCN2 current magnitude; 3) HA-MiRP1 accelerates the gating kinetics of HCN2 channels for both activation and deactivation at voltages relevant to cardiac diastolic depolarization; and 4) HA-MiRP1 does not alter the voltage dependence of HCN2 channel activation or the instantaneous component of HCN2 current. The results are consistent with our earlier oocyte study (4) and demonstrate that HA-MiRP1 expression in cardiac myocytes affects the expression and function of HCN2 channels. The results are consistent with the effect being due, at least in part, to increased expression of channel protein in the cell membrane, as would be expected if it involved facilitation of protein trafficking.
Over-expression studies should always be interpreted with caution, and this is particularly true when dealing with the KCNE family of proteins, which show remarkable promiscuity for interaction with pore-forming subunits of voltage gated potassium channels (12;13). However, we believe the interaction of MiRP1 (KCNE2) with HCN subunits is physiologically relevant for several reasons. First, we also detected both endogenous HCN2 and endogenous MiRP1 protein in neonatal rat ventricle and provided evidence of their co-assembly.
Thus, not only over-expressed proteins but also native HCN2 and MiRP1 co-assemble in cardiac myocytes. In addition, a recent study of ventricular tissue from aged rats, where pacemaker current is increased, reported elevated protein levels of MiRP1 with no significant change in protein levels of HCN2 (14) . This suggests that endogenous MiRP1 levels in the ventricle may be limiting, and therefore increases in MiRP1 protein level can augment pacemaker current, perhaps by more efficiently trafficking existing HCN2 subunits to the cell membrane. Our co-immunoprecipitation data in ventricle cultures (figure 5B) are consistent with that interpretation. It is possible a similar phenomenon occurs in the diseased ventricle, where pacemaker current magnitude also is increased (15;16) . Finally, the functional effect of MiRP1 appears to be specific to that isoform, in that MinK did not affect HCN2 current in myocytes, in agreement with our previous study in oocytes (4) .
Interactions between MiRP1 and HCN subunits also may contribute to the robust pacemaker current typical of the cardiac sinoatrial node. MiRP1 message levels are high in the sinoatrial node (4) in comparison to other cardiac regions. However, the effect of MiRP1 on pacemaker current kinetics in the sinoatrial node is uncertain. The dominant HCN isoform in the sinoatrial node is HCN4 (9;17), which activates too slowly when expressed in heterologous systems (17;18) to recapitulate the native sinoatrial node pacemaker current. A heterologous expression study confirmed that MiRP1 co-expression increases HCN4 current magnitude, but found that activation kinetics slowed further in the presence of MiRP1 (5). Ultimate resolution of the question of MiRP1-HCN interactions in the sinoatrial node, and the extent to which this contributes to the activation kinetics of native pacemaker current in this tissue, await future studies that suppress or reduce MiRP1 expression within the node and determine the impact on the endogenous pacemaker current.
The mechanism by which MiRP1 increases current magnitude when co-expressed with HCN2 is not certain. A chaperone effect may contribute, as has been suggested for other KCNE interactions (19) . However, we did not consistently observe increased recovery of HCN2 protein in the membrane fraction of ventricular cultures co-expressing HCN2 and HA-MiRP1, compared to those expressing HCN2 alone. This may reflect the presence of functionally distinct membrane pools, and indeed a recent study has provided evidence that HCN4 preferentially localizes to lipid rafts in both sinoatrial node and HEK293 cells (20) . Another study has demonstrated that when HCN subunits are expressed alone, N-linked glycosylation is essential for their trafficking to the membrane and observation of expressed currents (21) . It was found that HCN4 subunits can rescue glycosylation deficient HCN2 subunits by forming heteromultimers. In this regard, it would be interesting to determine if MiRP1 also can rescue glycosylation deficient HCN2 subunits.
Available data suggest that MiRP1 is the only member of the KCNE family to affect the function of HCN subunits. We previously did not observe any functional effect of MinK (KCNE1) on either HCN1 or HCN2 currents in oocytes (4), and in the present study failed to observe any functional effect of expressed MinK on expressed HCN2 currents in myocytes. It should be noted that we did observe co-immunoprecipitation of expressed MinK with expressed HCN2 in myocytes. However, another group using a yeast two-hybrid approach did not observe a direct interaction between HCN2 and MinK (5). Since only C-terminal domains were used in that study, a potential interaction of full length HCN2 and MinK cannot be ruled out, although investigation of MiRP1/HERG by Cui et al (22;23) support the functional importance of the channel subunit C-terminal, in that MiRP1 interaction affected the cAMP response. This may well be relevant to MiRP1/HCN interactions since both HERG and HCN channels possess a cyclic nucleotide binding domain in their C-termini. However, most available data on the structure-function relation of KCNE proteins relate to MinK/KCNQ1 interactions (12;24), and some of these studies suggest that the MinK C-terminal interacts with the pore region of KCNQ1, the so-called foot-in-the-door model (25) . Still other studies demonstrate the functional importance of residues within the transmembrane domain of KCNE proteins (24) . 
